Related Experiment Video

Updated: Jul 14, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants

Guillermo M Ruiz-Palacios1, M Lourdes Guerrero, Aurora Bautista-Márquez

  • 1Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico. gmrps@servidor.unam.mx

Pediatrics
|July 4, 2007
PubMed

Insights

This study shows a new oral rotavirus vaccine is safe and effective in infants. Two doses provided high protection against rotavirus gastroenteritis, comparable to natural immunity.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus gastroenteritis poses a significant global health burden, particularly in infants.
  • Immunization is a key strategy for reducing rotavirus-related morbidity and mortality.
  • Previous studies highlighted the need for effective rotavirus vaccines.

Purpose of the Study:

  • To evaluate the dose-response, immunogenicity, and efficacy of a novel oral, attenuated monovalent G1[P8] human rotavirus vaccine.
  • To assess vaccine performance in infants in Mexico, a region with established natural protection against rotavirus.
  • To compare vaccine efficacy against different severities of rotavirus gastroenteritis.

Main Methods:

  • A randomized, placebo-controlled trial involving 405 healthy infants.
  • Administration of two oral doses of the rotavirus vaccine at 2 and 4 months of age, concurrently with routine infant vaccinations.
  • Monitoring of infants up to 2 years of age, including weekly home visits and stool sample collection during gastroenteritis episodes for rotavirus testing.

Main Results:

  • The oral rotavirus vaccine demonstrated good tolerability and induced higher seroconversion rates compared to placebo.
  • Two vaccine doses achieved 80% efficacy against any rotavirus gastroenteritis and 95% against severe rotavirus gastroenteritis.
  • The highest vaccine concentration (10(5.8) infectious units) showed 100% efficacy against severe rotavirus gastroenteritis and 70% against severe gastroenteritis of any cause.

Conclusions:

  • The oral, live, attenuated human rotavirus vaccine is safe, immunogenic, and highly effective in preventing rotavirus gastroenteritis in infants.
  • The vaccine provides significant protection against both mild and severe forms of the disease.
  • The vaccine's protective efficacy is comparable to that conferred by natural rotavirus infection.
Abstract

More Related Videos

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...